JPMorgan Chase & Co. Raises Mettler-Toledo International (NYSE:MTD) Price Target to $1,285.00

Key Points

• JPMorgan Chase & Co. has raised its price target for Mettler-Toledo International from $1,200 to $1,285, maintaining a "neutral" rating for the stock, which suggests a potential downside of 1.51% from its previous close.
• Other analysts have varied opinions, with Bank of America increasing its target to $1,390 and Citigroup raising its target to $1,600, indicating general confidence in the stock despite mixed ratings.
• Mettler-Toledo reported a strong quarterly earnings performance, with earnings per share of $10.09, surpassing analysts' expectations and revealing a revenue increase of 3.9% year-over-year.

Mettler-Toledo International (NYSE:MTD - Get Free Report) had its target price lifted by research analysts at JPMorgan Chase & Co. from $1,200.00 to $1,285.00 in a research report issued on Thursday,Benzinga reports. The firm currently has a "neutral" rating on the medical instruments supplier's stock. JPMorgan Chase & Co.'s price objective indicates a potential downside of 1.51% from the stock's previous close.

Several other research analysts have also recently weighed in on the stock. Bank of America boosted their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a "neutral" rating in a report on Monday, September 22nd. Citigroup boosted their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a report on Thursday, August 21st. Robert W. Baird boosted their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. Evercore ISI boosted their target price on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an "outperform" rating in a research note on Tuesday. Finally, Weiss Ratings reiterated a "hold (c)" rating on shares of Mettler-Toledo International in a research note on Wednesday. Five research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $1,336.50.

Mettler-Toledo International Price Performance

NYSE:MTD traded down $23.88 during mid-day trading on Thursday, reaching $1,304.65. The stock had a trading volume of 8,443 shares, compared to its average volume of 166,687. The stock has a 50-day simple moving average of $1,276.00 and a two-hundred day simple moving average of $1,188.84. The stock has a market capitalization of $26.87 billion, a PE ratio of 32.98, a P/E/G ratio of 3.93 and a beta of 1.37. Mettler-Toledo International has a 12 month low of $946.69 and a 12 month high of $1,486.76.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $983.22 million for the quarter, compared to analysts' expectations of $957.41 million. During the same period last year, the firm posted $9.65 earnings per share. The firm's quarterly revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities analysts expect that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Buying and Selling

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the firm's stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total transaction of $376,227.00. Following the completion of the sale, the chief financial officer directly owned 5,095 shares in the company, valued at approximately $6,389,588.55. This trade represents a 5.56% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Gerry Keller sold 165 shares of the firm's stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the sale, the insider owned 94 shares of the company's stock, valued at approximately $123,012.16. This represents a 63.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,827 shares of company stock worth $2,371,208 in the last three months. 1.94% of the stock is owned by corporate insiders.

Institutional Trading of Mettler-Toledo International

Large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its position in shares of Mettler-Toledo International by 0.5% in the second quarter. Vanguard Group Inc. now owns 2,556,707 shares of the medical instruments supplier's stock worth $3,003,415,000 after purchasing an additional 13,342 shares during the period. Bank of New York Mellon Corp boosted its position in shares of Mettler-Toledo International by 71.3% in the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier's stock worth $1,062,257,000 after purchasing an additional 376,419 shares during the period. Alliancebernstein L.P. lifted its holdings in Mettler-Toledo International by 1.1% in the 2nd quarter. Alliancebernstein L.P. now owns 717,449 shares of the medical instruments supplier's stock worth $842,802,000 after purchasing an additional 8,121 shares in the last quarter. Geode Capital Management LLC boosted its stake in Mettler-Toledo International by 0.6% in the 2nd quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier's stock worth $681,489,000 after purchasing an additional 3,383 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its stake in Mettler-Toledo International by 5.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier's stock worth $568,032,000 after purchasing an additional 25,272 shares during the period. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.